We are live on ! Find out more
DMPV

Delphi Management Partners VIII Portfolio holdings

AUM $138M
1-Year Est. Return 56.74%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+56.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
-$18.1M
Cap. Flow
-$26M
Cap. Flow %
-20.53%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SENS icon
Senseonics Holdings Inc
SENS
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 95.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.17B
$97.4M 76.91%
1,000,000
KPTI icon
2
Karyopharm Therapeutics
KPTI
$216M
$23.4M 18.44%
150,867
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
$5.07M 4.01%
121,335
MREO
4
Mereo BioPharma
MREO
$49.5M
$814K 0.64%
256,734
SENS icon
5
Senseonics Holdings Inc
SENS
$267M
-492,315
Closed -$26M

Similar funds

Delphi Management Partners VIII's Q2 2021 Portfolio in Review

As of Q2 2021, Delphi Management Partners VIII held 5 positions worth $127M, down 13% from $145M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Delphi Management Partners VIII withdrew a net $26M in Q2 2021, closing 1 position. Its most notable exit was Senseonics Holdings Inc, an estimated $26M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

  • Delphi Management Partners VIII fully exited Senseonics Holdings Inc in Q2 2021, selling an estimated $26M.
  • Delphi Management Partners VIII's ten largest holdings make up 100% of its $127M portfolio in Q2 2021.
  • Delphi Management Partners VIII opened 0 new positions and closed 1 in Q2 2021.
  • Delphi Management Partners VIII's portfolio value fell 13% quarter-over-quarter to $127M.

Based on Delphi Management Partners VIII's 13F filing for Q2 2021, filed 12 Aug 2021.